Catalina Martinez-Jaramillo

Catalina Martinez-Jaramillo


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2009 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
JBJ. G. Bueno
J. G. Bueno
CMCatalina Martinez-Jaramillo
Catalina Martinez-Jaramillo
BZB. Zapata
B. Zapata
GSG. Sanclemente
G. Sanclemente
MGM. Gallego
M. Gallego
AMA. C. Mesa
A. C. Mesa

31 October 2019 in Blood
Verified
Journal Article
Open access
PDF file
ISIdo Somekh
Ido Somekh
MTMarini Thian
Marini Thian
DMDavid Medgyesi
David Medgyesi
NGNesrin Gülez
Nesrin Gülez
TMThomas Magg
Thomas Magg
KBKaan Boztug
Kaan Boztug
Somekh and colleagues identify CD137, a member of the tumor necrosis factor superfamily, as a novel cause of immunodeficiency associated with a risk of autoimmunity and lymphoid malignancy.

28 September 2018 in Colombia Medica
Verified
Journal Article
Open access
PDF file
CMCatalina Martinez-Jaramillo
Catalina Martinez-Jaramillo
CVClaudia Milena Trujillo Vargas
Claudia Milena Trujillo Vargas
Bi-allelic mutations in LRBA (from Lipopolysaccharide-responsive and beige-like anchor protein) result in a primary immunodeficiency with clinical features ranging from hypogammaglobulinemia and lymphoproliferative syndrome to inflammatory bowel disease and heterogeneous autoimmune manifestations. LRBA deficiency has been shown to affect vesicular trafficking, autophagy and apoptosis, which may lead to alterations of several molecules and processes that play key roles for immunity. In this review, we will discuss the relationship of LRBA with the endovesicular system in the context of receptor trafficking, autophagy and apoptosis. Since these mechanisms of homeostasis are inherent to all living cells and not only limited to the immune system and also, because they are involved in physiological as well as pathological processes such as embryogenesis or tumoral transformation, we envisage advancing in the identification of potential pharmacological agents to manipulate these processes.

1 November 2018 in Viral Immunology
Verified
Journal Article
Closed access
YUYerly Magnolia Useche
Yerly Magnolia Useche
MRMarcelo Ribeiro-Alves
Marcelo Ribeiro-Alves
BRBerta-Nelly Restrepo
Berta-Nelly Restrepo
DSDoris Martha Salgado
Doris Martha Salgado
CNCarlos F. Narváez
Carlos F. Narváez
GBGabriel Bedoya
Gabriel Bedoya
Functional immunological evidence supports the impact that the host genetic variability has on the susceptibility to develop asymptomatic or symptomatic dengue infection. Children are more prone to develop severe dengue. Thus, we have evaluated possible associations between single-nucleotide polymorphisms (SNPs) located in immune genes and the development of symptomatic dengue in children from two Colombian populations with differences in genetic backgrounds and geographical features. We genotyped 15 SNPs (in 12 genes) in 298 symptomatic children and 648 healthy controls. Ancestry proportions (APs) were inferred by genotyping 29 ancestry informative markers. We observed four SNPs associated with susceptibility to develop dengue in NOD1, RIPK2, MICB, or PLCE1 genes. Conversely, we found one SNP in TNF gene and two haplotypes in the IKBKE gene associated with resistance to develop dengue. These associations were adjusted by gender, APs, and the population of origin because the association of polymorphisms may be different in admixed populations like Colombian. To our knowledge, this is the first reported association study with dengue in IKBKE, RIPK2, and NOD1 genes. We have also confirmed previously reported associations in MICB and PLCE1 genes with dengue. Overall, our results contribute to the understanding of the genetic susceptibility/resistance to develop symptomatic dengue. Nevertheless, these associations must be validated through functional analysis.

24 September 2019 in Colombia Medica
Verified
Journal Article
Open access
PDF file
CMCatalina Martinez-Jaramillo
Catalina Martinez-Jaramillo
SGSebastian Gutierrez-Hincapie
Sebastian Gutierrez-Hincapie
JAJulio César Orrego Arango
Julio César Orrego Arango
GVGloria María Vazuez-Duque
Gloria María Vazuez-Duque
RERuth María Erazo-Garnica
Ruth María Erazo-Garnica
CTClaudia Milena Trujillo-Vargas
Claudia Milena Trujillo-Vargas
Background: LPS-responsive beige -like anchor protein (LRBA) deficiency is a primary immunodeficiency disease caused by loss of LRBA protein expression, due to biallelic mutations in LRBA gene. LRBA deficiency patients exhibit a clinically heterogeneous syndrome. The main clinical complication of LRBA deficiency is immune dysregulation. Furthermore, hypogammaglobulinemia is found in more than half of patients with LRBA-deficiency. To date, no patients with this condition have been reported in Colombia Objective: To evaluate the expression of the LRBA protein in patients from Colombia with clinical phenotype associated to LRBA-deficiency. Methods: In the present study the LRBA-expression in patients from Colombia with clinical phenotype associated to LRBA-deficiency was evaluated. After then, the clinical, the immunological characteristics and the possible genetic variants in LRBA or other genes associated with the immune system in patients that exhibit decrease protein expression was evaluated. Results: In total, 112 patients with different clinical manifestations associated to the clinical LRBA phenotype were evaluated. The LRBA expression varies greatly between different healthy donors and patients. Despite the great variability in the LRBA expression, six patients with a decrease in LRBA protein expression were observed. However, no pathogenic or possible pathogenic biallelic variants in LRBA, or in genes related with the immune system were found. Conclusion: LRBA expression varies greatly between different healthy donors and patients. Reduction LRBA-expression in 6 patients without homozygous mutations in LRBA or in associated genes with the immune system was observed. These results suggest the other genetic, epigenetic or environmental mechanisms, that might be regulated the LRBA-expression.

11 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
LJLuis Jose Jaramillo-Valverde
Luis Jose Jaramillo-Valverde
Gilderlanio AraújoGilderlanio Araújo
Gilderlanio Araújo
JPJulio A. Poterico
Julio A. Poterico
CMCatalina Martinez-Jaramillo
Catalina Martinez-Jaramillo
VLVicky Roa Linares
Vicky Roa Linares
HGHEINNER GUIO
HEINNER GUIO
Background: Genetic factors influencing immune response pathways in Andean populations may underlie adaptations to high-altitude environments. To investigate transcriptomic signatures associated with altitude, we analyzed immune-related gene expression across individuals residing at different elevations. Methods: We recruited 62 Peruvian volunteers, predominantly from rural regions with high proportions of indigenous ancestry, living at low and high altitudes. Peripheral blood mononuclear cells (PBMCs) were stimulated with bacterial lipopolysaccharide (LPS), Pam3CSK4 (a synthetic triacylated lipopeptide), and R848 (an imidazoquinoline analog of viral nucleic acids). Population structure and ancestry were characterized, and transcriptome-wide differential expression analyses were performed. Results: We identified 30 genes with significant altitude-associated expression differences, including 22 downregulated (e.g., FN1, CD36, FOS ) and nine upregulated genes. Functional enrichment indicated roles in acute inflammatory response, leukocyte migration, and positive regulation of myeloid leukocyte differentiation. Conclusions: High- and low-altitude Andean individuals exhibit distinct immune gene expression profiles, defining a population-specific transcriptomic signature that may reflect altitude-related immune adaptation. AUTHOR SUMMARY: Andean populations exhibit genetic adaptations in immune response pathways, potentially linked to high-altitude living. To investigate this, we conducted genome-wide and transcriptome-wide analyses to identify immune-related gene expression differences between high- and low-altitude residents. We analyzed the genetic structure and ancestry of Peruvian individuals (primarily rural, with strong indigenous ancestry) living at different altitudes. Peripheral blood mononuclear cells (PBMCs) from 62 volunteers were stimulated with bacterial (LPS, Pam3CSK4) and viral (R848) mimics to assess immune responses. Differential expression analysis identified 22 down-regulated genes (e.g., FN1, CD36, FOS ) and nine up-regulated genes, enriched in acute inflammatory response, leukocyte migration, and myeloid leukocyte differentiation. Our findings reveal a unique immune gene expression profile in Andean highlanders, distinct from other populations, suggesting adaptive modulation of both innate and adaptive immunity in response to high-altitude challenges.